Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lewis

Showing results (1001-1010 of 1,038) with videos related to

Pageof 104
Sort By:
The Journal of Clinical Investigation|November 11, 2025
Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2Jessica N Maung, Rebecca L Schill, Akira Nishii, et al.
The Journal of Clinical Investigation|February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancerNa Zhao, Jin Cao, Longyong Xu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Cellular stemness identifies high-risk ductal carcinoma <i>in situ</i> and offers a therapeutic interception opportunityE Schueddig, V Kochat, E Arslan, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Molecular Cancer Therapeutics|April 19, 2024
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus RecommendationsFunda Meric-Bernstam, Michael W Lloyd, Soner Koc, et al.
Molecular Cancer Therapeutics|July 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor CombinationsAnh Minh Tran Huynh, Jonathan T Lei, Rachel Brough, et al.
Molecular Ecology Resources|May 29, 2021
DROP: Molecular voucher database for identification of Drosophila parasitoidsChia-Hua Lue, Matthew L Buffington, Sonja Scheffer, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T Lei, Lacey E Dobrolecki, Chen Huang, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Pageof 104

Showing results (1001-1010 of 1,038) with videos related to

Sort By:
Pageof 104
The Journal of Clinical Investigation|November 11, 2025
Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2Jessica N Maung, Rebecca L Schill, Akira Nishii, et al.
The Journal of Clinical Investigation|February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancerNa Zhao, Jin Cao, Longyong Xu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Cellular stemness identifies high-risk ductal carcinoma <i>in situ</i> and offers a therapeutic interception opportunityE Schueddig, V Kochat, E Arslan, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Molecular Cancer Therapeutics|April 19, 2024
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus RecommendationsFunda Meric-Bernstam, Michael W Lloyd, Soner Koc, et al.
Molecular Cancer Therapeutics|July 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor CombinationsAnh Minh Tran Huynh, Jonathan T Lei, Rachel Brough, et al.
Molecular Ecology Resources|May 29, 2021
DROP: Molecular voucher database for identification of Drosophila parasitoidsChia-Hua Lue, Matthew L Buffington, Sonja Scheffer, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T Lei, Lacey E Dobrolecki, Chen Huang, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Pageof 104